Orally Administered Natural Lipid Nanoparticle-Loaded 6-Shogaol Shapes the Anti-Inflammatory Microbiota and Metabolome

The past decade has seen increasing interest in microbiota-targeting therapeutic strategies that aim to modulate the gut microbiota’s composition and/or function to treat chronic diseases, such as inflammatory bowel disease (IBD), metabolic symptoms, and obesity. While targeting the gut microbiota i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chunhua, Long, Dingpei, Sung, Junsik, Alghoul, Zahra, Merlin, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472296/
https://www.ncbi.nlm.nih.gov/pubmed/34575431
http://dx.doi.org/10.3390/pharmaceutics13091355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472296/
https://www.ncbi.nlm.nih.gov/pubmed/34575431
http://dx.doi.org/10.3390/pharmaceutics13091355

Ejemplares similares